Literature DB >> 28648894

Compositional analysis of endogenous porphyrins from Helicobacter pylori.

A Battisti1, P Morici2, G Signore3, F Ghetti2, A Sgarbossa2.   

Abstract

Bacteria able to accumulate porphyrins can be inactivated by visible light irradiation thanks to the photosensitizing properties of this class of aromatic pigments (photodynamic therapy, PDT). Since the bacterial resistance to antibiotic is growing, PDT is becoming a valid alternative. In this context, the pathogen Helicobacter pylori (Hp) is a suitable target for PDT since it spontaneously produces and accumulates porphyrins. It is then important to understand the spectroscopic behavior of these endogenous species to exploit them as photosensitizers, thus improving the results given by the application of PDT in the treatment of Hp infections. In this work we extracted porphyrins from both a laboratory-adapted and a virulent strain of Hp, and we performed spectroscopic and chromatographic experiments to collect information about the composition and the spectrophotometric features of the extracts. The main components of the porphyrin mixtures were identified and their relative contribution to the global red fluorescence was examined.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28648894     DOI: 10.1016/j.bpc.2017.06.006

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  2 in total

Review 1.  Antimicrobial blue light inactivation of pathogenic microbes: State of the art.

Authors:  Yucheng Wang; Ying Wang; Yuguang Wang; Clinton K Murray; Michael R Hamblin; David C Hooper; Tianhong Dai
Journal:  Drug Resist Updat       Date:  2017-10-13       Impact factor: 18.500

2.  The in vitro Photoinactivation of Helicobacter pylori by a Novel LED-Based Device.

Authors:  Paola Morici; Antonella Battisti; Giuseppe Tortora; Arianna Menciassi; Giovanni Checcucci; Francesco Ghetti; Antonella Sgarbossa
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.